Skip to main content

Table 2 Microbiological data

From: An international survey on aminoglycoside practices in critically ill patients: the AMINO III study

Variables

n

Microbiological sample (n = 930)

826 (89%)

Number of pathogens identified (n = 511)

 

 1

317 (62%)

 2

121 (24%)

 3 and more

73 (14%)

Pathogens (n = 798)

 

 Gram-positive bacteria

255 (32%)

  Staphylococcus/S. aureus

120 (15%)/84 (10.5%)

  Streptococci

64 (8%)

  Enterococci

67 (8.4%)

 Gram-negative bacteria

453 (58%)

  Escherichia coli

166 (21%)

  Klebsiella spp.

70 (8.8%)

  Pseudomonas aeruginosa

73 (9%)

  Enterobacter spp.

41 (5%)

  Acinetobacter baumannii

9 (1%)

  Stenotrophomonas maltophila

5 (0.6%)

 Anaerobes bacteria

24 (3%)

 Fungi/Candida

33 (4%)/31 (3.9%)

Susceptibility testing (n = 322)

 

 AG susceptibility categories (S/I/R)

254 (79%)/14 (4%)/54 (17%)

  1. Results are given as numbers and percentages
  2. AG: aminoglycoside; MIC: minimal inhibitory concentration; R: resistant; I: intermediate; S: susceptible